News & Media
Magnolia Medical’s Steripath® Initial Specimen Diversion Device® Only Device Clinically Proven to Meet CDC’s New Guidelines to Reduce Blood Culture Contamination
August 23, 2022
Magnolia Medical Technologies Wins Patent-Infringement Lawsuit against Kurin, Inc.
July 29, 2022
A “Triple Aim” Case Study: A Systematic Approach for Diagnostic and Antimicrobial Stewardship
June 14, 2022
Magnolia Medical Launches New Company Website to Educate Healthcare Providers on Blood Culture Contamination and to Increase Awareness of the Devastating Impact of Sepsis Misdiagnosis
June 2, 2022
Optimizing Efficiency in Clinical Microbiology Labs: Steps to Avoid Unnecessary Tests Through Diagnostic and Antimicrobial Stewardship
May 25, 2022
Magnolia Medical Announces Successful FDA Field Inspection Results and Formal Warning Letter Close-Out
May 24, 2022